News
(Sodium is an inactive ingredient in the medication that helps it dissolve and be absorbed in your body.) Montelukast is the generic version of the brand-name drug Singulair. If you and your ...
DRL to Sell Generic Version of Montelukast Sodium in US Dr Reddy’s Laboratories has announced that it has launched the generic version of its Montelukast Sodium oral granules in the United States.
Singulair’s manufacturer, Merck & Co., transitioned some of its products to Organon, including Singular (monelukast sodium), in June ... group — called the Montelukast (Singulair) Side Effects ...
Montelukast is a generic drug that’s prescribed for allergies and certain lung conditions. Montelukast is not known to interact with other medications. This article will focus on interactions ...
Singulair comes in generic versions with the following names: Montelukast Montelukast Na Montelukast sodium The name-brand and generic versions are prescribed to adults and children. Early ...
The US researchers found that the drug, sold under the brand name Singulair and generically as montelukast, attaches to multiple brain receptors critical to psychiatric functioning. By 2019 ...
U.S. government researchers have found that a widely prescribed asthma drug originally sold by Merck & Co may be linked to serious mental health problems for some patients, according to a ...
Montelukast, developed by Merck and Co., was approved by the FDA in 1998 and marketed under the brand name ‘Singulair’. The oral medication was approved to be prescribed daily for long-term ...
There were no differences in mental health outcomes between montelukast and long-acting beta-agonists. Psychiatric events rose over time, likely due to increased screening, diagnoses and awareness.
Montelukast (Singulair) held no elevated risk of depression, anxiety, suicidality, or behavioral problems for children, according to a new study that throws further doubt on the black box warning ...
Montelukast attenuates EIB, but its protective effect against airway narrowing from EVH has not been investigated. Objective: To examine the effectiveness of montelukast after exercise and after EVH.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results